Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
DDDr. Dereck Mush, MD, MBA
Jul 30
What they do
Quibim develops medical software that extracts quantitative imaging biomarkers from MRI, CT, and PET scans. The company's platform helps oncology, neurology, and immunology clinicians and pharmaceutical researchers evaluate disease progression and monitor treatment efficacy through objective tissue analysis.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Quantitative imaging biomarkers
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- Valencia, Spain
- Region
- Europe
- Founded
- 2015
- Total funding
- $15M raised
Notable investors: Adara Ventures, Amadeus Capital Partners, Partech, TechTransfer UPV.
Also in Imaging & Diagnostics
Related on The Signal
New diagnostic tools are trying to shrink endometriosis's decade long diagnosis gap
DDDr. Dereck Mush, MD, MBA
Feb 5
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
DDDr. Dereck Mush, MD, MBA
Sep 13
Liquid biopsy monitoring is turning precision oncology into a continuous process, not a one time test
DDDr. Dereck Mush, MD, MBA
Jun 10